On the recordFebruary 26, 2014
It is appropriate, it is legitimate, it is what oversight committees should be doing, and I hope it is the first step towards passing legislation that will effectively deter and punish those who put Americans' health at risk with counterfeit pharmaceuticals.
Source
congress.gov




